Rule 26 compliance
August 17 2007 - 5:06AM
UK Regulatory
RNS Number:3127C
Tepnel Life Sciences PLC
17 August 2007
Tepnel Life Sciences PLC
Rule 26 compliance
Manchester, UK, 17 August 2007 Tepnel Life Sciences PLC (AIM: TED), the
international Molecular Diagnostics and Research Products & Services group, is
pleased to announce that the information required by AIM Rule 26 is available on
its website at www.tepnel.com.
For Further Information:
Tepnel Life Sciences plc
Ben Matzilevich, CEO
Carol Smith
Tel: 0161 946 2200
Capital MS&L
Mary Clark or Catie Corcoran
Tel: +44 20 7307 5330
Seymour Pierce Limited
Mark Percy
Tel: +44 20 7107 8000
Notes to Editors
About Tepnel Life Sciences plc
Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences
products and services group with two divisions, Molecular Diagnostics and
Research Products & Services. The Company has laboratories, manufacturing and
operations in the USA, UK and France with 195 employees. TLS provides test
kits, reagents and services to two highly synergistic markets, these being
Molecular Diagnostics and Biomedical Research. The company's strategy has been
to identify high growth niche opportunities within these multi-billion pound
markets. TLS focuses on these niche opportunities with internally developed
products, patents, expertise and know-how as well as strategic acquisitions, to
develop a leadership position within these defined market segments.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCGUUAURUPMUBM
Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024